News | June 16, 2022
Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Glenmark is the first company in India to market the innovative FDC of Indacaterol
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
Active pharmaceutical ingredients revenue for the quarter was at Rs 913 crore
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
JB, in its new avatar, emerges as the fastest growing pharmaceuticals company in India
The centre works with active pharmaceutical ingredients (APIs) and can utilize innovative concepts with model APIs
'Hello Skin' has been developed in collaboration with the IADVL (Indian Association of Dermatologists, Venereologists and Leprologists)
Subscribe To Our Newsletter & Stay Updated
